Average Co-Inventor Count = 5.69
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Combinatorx, Incorporated (5 from 10 patents)
2. Infinity Pharmaceuticals, Inc. (3 from 108 patents)
3. Infinity Discovery, Inc. (2 from 12 patents)
4. Zalicus, Inc. (2 from 5 patents)
5. Canthera Therapeutics Inc. (2 from 2 patents)
6. The General Hospital Corporation (1 from 2,893 patents)
7. Massachusetts General Hospital Corporation (1 from 83 patents)
14 patents:
1. 8349832 - Compounds and compositions for treating cancer
2. 8318737 - Compounds and compositions for treating cancer
3. 8236956 - Cyclopamine analogues and methods of use thereof
4. 8080553 - Methods and reagents for the treatment of immunoinflammatory disorders
5. 7915265 - Combinations for the treatment of immunoinflammatory disorders
6. 7875628 - Cyclopamine analogues and methods of use thereof
7. 7851637 - Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
8. 7407967 - Cyclopamine analogues and methods of use thereof
9. 7253155 - Combinations for the treatment of immunoinflammatory disorders
10. 7230004 - Cyclopamine analogues and methods of use thereof
11. 7148216 - Combinations of drugs for the treatment of neoplastic disorders
12. 6846816 - Combinations of drugs for the treatment of neoplastic disorders
13. 6693125 - Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders
14. 6569853 - Combinations of chlorpromazine and pentamidine for the treatment of neoplastic disorders